RDC Redcare Pharmacy NV

69.69USD63.40 EUR · XETRA-1.93%Mkt Cap: 1.40B USDP/E: —

Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beaut…

Institutional holders11 on file

Key Statistics

Company
Market Cap1.40B USD
Enterprise Value1.67B USD
Revenue (TTM)3.68B USD
Gross Profit728.88M USD
Net Income (TTM)-41.44M USD
Revenue/Share160.75 USD
Last Price69.69 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees2.2K
CountryDE
SectorHealthcare
IndustryPharmaceutical Retailers
ISINNL0012044747
Valuation
P/E (Trailing)—
P/E (Forward)47.05
PEG—
EV/EBITDA49.68
EV/Revenue0.45
P/S0.38
P/B2.78
EPS (TTM)-1.80 USD
EPS (Forward)1.48 USD
52W Range
33.2067% of range87.83
52W High87.83 USD
52W Low33.20 USD
Profitability
Gross Margin22.55%
Oper. Margin0.29%
EBITDA Margin0.91%
Profit Margin-1.28%
ROE-8.21%
ROA-3.10%
ROIC-3.56%
ROCE-3.66%
Growth
Revenue Growth17.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF34.08M USD
CapEx (TTM)130.37M USD
FCF Margin-1.77%
FCF Yield-4.63%
Net Debt244.13M USD
Net Debt/EBITDA7.28
Net Debt/FCF—
Balance Sheet
Debt/Equity0.91
Current Ratio1.62
Quick Ratio0.81
Book Value/Sh25.10 USD
Cash/Share7.24 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)100.69 USD
Upside (mean)+44.5%
Target Range79.14 USD – 137.40 USD
79.14+44.5% to mean137.40
# Analysts10
Ownership
Shares Out.20.11M
Float19.20M
Insiders18.70%
Institutions36.16%
Technical
SMA 5075.94 (-8.2%)
SMA 20063.67 (+9.4%)
Beta1.45
S&P 52W Chg8.68%
Avg Vol (30d)62.67K
Avg Vol (10d)43.76K
Technical Indicators
RSI (14)35.3
MACD-1.6467
MACD Signal-0.4032
MACD Hist.-1.2435
BB Upper88.01 USD
BB Middle78.57 USD
BB Lower69.13 USD
BB Width24.03%
ATR (14)3.432 USD
Vol Ratio (20d)1.18x

About Redcare Pharmacy (ETR: RDC)

›

Redcare Pharmacy (ETR: RDC) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector, and reports about 2,163 employees.

The shares were at 63.40 EUR on 20 November 2026, up 5.5% over 52 weeks. Its 52-week range is 30.20 EUR to 79.90 EUR: the price is 20.7% below the high and 109.9% above the low.

Its market capitalisation is 1.28B EUR.

Redcare Pharmacy reports return on equity of -8.2%, an operating margin of 0.3% and revenue up 17.7% year over year.

Its debt exceeds its cash by 222.10M EUR, a debt-to-equity ratio of 0.91. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 10 analysts cover the stock, with an average rating of Buy; their mean price target of 91.60 EUR is 44.5% above the current price. The next earnings report is expected on 3 March 2027.